TVGN - Tevogen Bio Holdings Inc.
7.79
0.040 0.513%
Share volume: 34,538
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$7.75
0.04
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-28-2024 | 08-14-2024 | 11-19-2024 | 05-14-2025 | 11-14-2025 | |
| Assets | ||||||
| Total Assets | 3.363 M | 3.310 M | 4.289 M | 4.073 M | 4.494 M | |
| Current Assets | 2.400 M | 2.447 M | 3.528 M | 3.078 M | 2.122 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.318 M | 1.135 M | 2.331 M | 1.975 M | 1.037 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 418.099 K | 377.547 K | 336.994 K | 255.889 K | 163.930 K | |
| Other Assets | 545.387 K | 485.949 K | 424.761 K | 739.482 K | 2.208 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 3.363 M | 3.310 M | 4.289 M | 4.073 M | 4.494 M | |
| Total liabilities | 9.166 M | 10.944 M | 10.480 M | 11.793 M | 12.318 M | |
| Total current liabilities | 8.938 M | 10.612 M | 10.416 M | 8.720 M | 6.737 M | |
| Accounts Payable | 5.212 M | 6.666 M | 5.838 M | 4.665 M | 3.312 M | |
| Other liabilities | 227.761 K | 332.208 K | 64.203 K | 3.073 M | 5.580 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 227.761 K | 332.208 K | 64.203 K | 3.073 M | 5.580 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -12.216 M | -10.434 M | -12.990 M | -16.520 M | -16.624 M | |
| Common stock | 76.177 M | 87.622 M | 90.950 M | 107.232 M | 118.359 M | |
| Retained earnings | -88.393 M | -98.056 M | -103.941 M | -123.752 M | -134.983 M |